RecruitingNCT04891432

Comparison of Surgical Outcomes Between Pre Sympathetic Plexus and Post Sympathetic Plexus Approach


Sponsor

Seoul National University Hospital

Enrollment

200 participants

Start Date

Apr 8, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

There would be no difference in the risk of sympathetic plexus damage between the pre sympathetic plexus approach and the post sympathetic plexus approach.


Eligibility

Min Age: 20 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study compares two surgical approaches for a spinal fusion procedure called lateral lumbar interbody fusion (LLIF), used to treat degenerative disc disease in the lower back. The two approaches differ in how the surgeon navigates around a network of nerves in the area. The goal is to find out which approach leads to better outcomes and fewer complications. You may be eligible if: • You are between 20 and 80 years old • You have been diagnosed with lumbar degenerative disease • You need a spinal fusion of 1 to 2 levels between L2 and S1 • You have not had previous lumbar surgery You may NOT be eligible if: • You have had prior lumbar surgery • You have significant muscle weakness (motor grade III or lower) • You have a neuropsychiatric condition such as depression • You have inflammatory musculoskeletal disease or an active infection • You have cancer • You do not wish to participate in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELateral lumbar interbody fusion

oblique lumbar interbody fusion or direct lateral interbody fusion


Locations(1)

Seoul National University Hospital

Seoul, Korea, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04891432


Related Trials